| Literature DB >> 27320922 |
Xia Hu1, Morayo G Adebiyi2, Jialie Luo3, Kaiqi Sun2, Thanh-Thuy T Le4, Yujin Zhang4, Hongyu Wu4, Shushan Zhao4, Harry Karmouty-Quintana4, Hong Liu2, Aji Huang4, Yuan Edward Wen4, Oleg L Zaika5, Mykola Mamenko5, Oleh M Pochynyuk5, Rodney E Kellems2, Holger K Eltzschig6, Michael R Blackburn2, Edgar T Walters5, Dong Huang7, Hongzhen Hu3, Yang Xia8.
Abstract
The molecular mechanisms of chronic pain are poorly understood and effective mechanism-based treatments are lacking. Here, we report that mice lacking adenosine deaminase (ADA), an enzyme necessary for the breakdown of adenosine, displayed unexpected chronic mechanical and thermal hypersensitivity due to sustained elevated circulating adenosine. Extending from Ada(-/-) mice, we further discovered that prolonged elevated adenosine contributed to chronic pain behaviors in two additional independent animal models: sickle cell disease mice, a model of severe pain with limited treatment, and complete Freund's adjuvant paw-injected mice, a well-accepted inflammatory model of chronic pain. Mechanistically, we revealed that activation of adenosine A2B receptors on myeloid cells caused nociceptor hyperexcitability and promoted chronic pain via soluble IL-6 receptor trans-signaling, and our findings determined that prolonged accumulated circulating adenosine contributes to chronic pain by promoting immune-neuronal interaction and revealed multiple therapeutic targets.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27320922 PMCID: PMC5662192 DOI: 10.1016/j.celrep.2016.05.080
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423